Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.
Paediatr Respir Rev
; 30: 34-41, 2019 Apr.
Article
em En
| MEDLINE
| ID: mdl-30201135
ABSTRACT
Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Displasia Broncopulmonar
/
Glucocorticoides
/
Anti-Inflamatórios
Limite:
Female
/
Humans
/
Newborn
/
Pregnancy
Idioma:
En
Revista:
Paediatr Respir Rev
Assunto da revista:
PEDIATRIA
Ano de publicação:
2019
Tipo de documento:
Article